Behavioral Neuroscience – News and Features

NIMH study found a variation in a gene called GRIK4 appears to make people with depression more likely to respond to citalopram than are people without variation.

Curidium Medica plc has announced that it has joined the US-based Personalized Medicine Coalition.

The State Government is funding new research which could lead to a genetic test and early intervention programs to better treat schizophrenia.

Nanogen acquires rights to genetic markers related to schizophrenia and responses to antipsychotic therapies from Diagnostics CRC and Queensland University of Technology

GAIN will use the Genome-Wide Human SNP Array 6.0 for a series of studies designed to identify the genetic causes of common, complex diseases.

Cold Spring Harbor Laboratory has received $25 million gift from Theodore and Vada Stanley to establish the Stanley Center for Psychiatric Genomics on its Long Island campus.

Two proteins that are implicated in autism have been found to control the strength and balance of nerve-cell connections, UT Southwestern Medical Center researchers have found.

The National Center for Research Resources will provide $20.65 million for 14 High-End Instrumentation grants that will fund equipment required to advance biomedical research.

Eksigent signs distribution agreement with Bionoetikos Ltd. covering sales and service of Eksigent’s NanoLC™ HPLC product line in Southeast Asia.

Lipomics has entered into a two year research agreement with Duke University in several key clinical areas to identify pharmacometabolomic markers.